Latest Asset Development News

Vysarn Limited has delivered record financial results for FY25, driven by strong demand across its water services segments and successful integration of key acquisitions. The company is poised for further growth in FY26, expanding its national footprint and advancing strategic projects.

Island Pharmaceuticals reported promising Phase 2a/b trial results for its dengue drug ISLA-101 and secured a strategic acquisition of the broad-spectrum antiviral Galidesivir, bolstering its pipeline and balance sheet.

Microba Life Sciences reports strong Q4 FY25 growth driven by record microbiome test sales and clinician adoption in Australia and the UK, while advancing its therapeutics pipeline and targeting regional break-even in FY26.

Finder Energy has spotlighted its Kuda Tasi and Jahal oil development opportunity at the APAC Energy Capital Assembly, revealing a robust resource base and a streamlined development strategy promising rapid returns.

Raiden Resources has increased its ownership in the Vuzel Gold Project from 51% to 75%, marking a key milestone driven by promising near-surface and high-grade gold discoveries. The company eyes further ownership gains as drilling continues.

Brightstar Resources outlines an ambitious growth plan to boost gold production from 20koz to 200koz per annum by 2029, anchored by upcoming feasibility studies and resource upgrades across its Western Australian hubs.

Anax Metals has locked in a $3.3 million convertible note investment from Mineral Development Partners, with conditional commitments for up to $100 million to advance the Whim Creek Project and establish a Pilbara base metals hub.

AdAlta Limited has announced a pro rata renounceable rights offer to raise approximately $1.29 million, aiming to fund its strategic pivot towards licensing CAR-T cell therapies through its subsidiary AdCella. The offer includes new shares and options, underpinned by key insiders and an underwriting agreement.

Pure Hydrogen Corporation has marked significant progress in its clean energy transition, delivering Australia's first hydrogen fuel cell garbage truck and securing multi-million dollar contracts with industry leaders TOLL Transport and Heidelberg Materials.

Starpharma reports steady progress in its DEP® drug development programs, launches new marketing campaigns in key regions, and maintains a strong cash position of $17.2 million as it refines clinical strategies and partnerships.

Cazaly Resources has exercised its option to earn up to 80% of the Goongarrie Gold Project, initiating planned drilling at key prospects while maintaining a solid cash position of $3.3 million at quarter-end.

NH3 Clean Energy has reported a significant uplift in the value of its WAH2 clean ammonia project following completion of Pre-FEED engineering, alongside strategic export agreements and a recent capital raise.